Colgate Q4 Review – Strong Operational Performance Continues: Dolat Capital

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Colgate-Palmolive India Ltd.’s Q4 FY21 revenues were marginally ahead, but Ebitda and adjusted profit after tax were significantly ahead of our expectation.

Domestic business posted 20.2% sales growth during Q4. All categories witnessed positive growth driven by household penetration.

A 300 basis points expansion in gross margin was a key positive. With better product mix, and calibrated price increases, we expect gross margins to remain healthy.

However, advertising and promotion spends decreased significantly by 290 basis points.

Nevertheless, we believe that the advertising and promotion spends would remain elevated to support volume growth and gain market share.

Click on the attachment to read the full report:

Dolat Capital Colgate Palmolive Q4FY21 Result Update.pdf


This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Most Related Links :
usnewsmail Governmental News Finance News

Source link

Back to top button